Fig. 3From: Immune Activation Effects at Different Irradiated Sites and Optimal Timing of Radioimmunotherapy in Patients with Extensive-Stage Small Cell Lung Cancer: a Real-World AnalysisDatasets on Survival were Available for 40 PatientsBack to article page